Symbios Technologies
Website
Symbios Technologies is a privately-held startup technology company developing world-leading dynamic aqueous plasma technology platforms for biotherapeutic, water treatment, and specialty manufacturing applications. Our leadership team and Business & Scientific Advisory Board are seasoned experts with deep industry experience in plasma technology, pharmaceuticals, water, wastewater, energy, finance, business, and engineering.

Strengthened by initial technology development and vetting-performed at a combination of institutions, such as the University of Wisconsin, Colorado State University, and the U.S. Naval Research Laboratory, and by its intellectual property portfolio-Symbios Technologies is commercializing its disruptive advanced low-cost aqueous plasma technology, the Symbios Tubular Plasma Reactor (TPR), to protect human health, preserve the environment, and clean water as well as improve production economics and sustainability.
Services
We're always on the lookout for talented people with a passion for sustainable water technology! Do you have a passion to contribute beyond receiving a paycheck? Do you have a desire to work in an environment where teamwork is the cornerstone of our success as we seek to create new technologies to solve big problems facing countries, industries, and municipalities?
Our customers need improved, lower-cost oxidation methods for ultrapure, process, and wastewater applications to remove organics and for microbial elimination.

The Symbios TPR4000 is the solution that can increase productivity and product quality for manufacturing processes, improve water treatment economics for utilities, provide new wastewater, chemotherapeutic, and anti-infective treatment for healthcare, and facilitate flow back and produced water cleanup and reuse for oil & gas extraction.
Symbios Technologies' customers vary widely and come from multiple disciplines driven by an overwhelming need for advanced water treatment technologies as clean water becomes a more precious resource. For manufacturing applications, process waters must meet exacting requirements for customer and regulatory acceptance of the finished product.
One of the most promising opportunities within the biosciences for application of the TPR4000 is for use in selective cancer therapies. Despite significant chemotherapeutic advances due to new drugs and combinatorial therapies over the past decades, cancer is still the second-leading cause of death in the United States.
Food and beverage companies are pursuing advanced and innovative technologies to enhance water management tasks. Consumers, municipalities they operate in, and regulators have pushed for this industry to minimize energy and water consumption. Companies are being rewarded for emphasizing alternative technologies that demonstrate their commitment to water conservation and reuse.
Reviews (1)
Jp Casey
Jp Casey
Nov 02, 2019
Report
Still don’t know what this place is but thanks 🙏 for keeping us safe by researching diseases that may affect us and also others